Ads
-
Related paper
- COVID-19 drugs: A necessary strategy for living with COVID-19 in the new normal and the mutations of the SARS-CoV-2 such as omicron variant
- Induction of Neutralizing Immunity against SARS-CoV-2 Omicron Variant by COVID-19 Vaccine Boosters
- THE OMICRON VARIANT BREAKS THE EVOLUTIONARY LINEAGE OF SARS-COV2 VARIANTS
- Identification of therapeutic potential phytochemicals against the SARS CoV-2 spike protein of omicron variant by Molecular docking techniques
- THE INDIA MUTATIONS AND B.1.617 DELTA VARIANTS: IS THERE A GLOBAL "STRATEGY" FOR MUTATIONS AND EVOLUTION OF VARIANTS OF THE SARS-COV2 GENOME?
- EFFECTS OF DRUGS ON SPIKE GLYCOPROTEIN OF SARS-COV 2 IN CONTROL OF COVID-2019
- Use of the Remaining Sample from the Panbio COVID-19 Antigen Rapid Test Device for the Molecular Screening of the SARS-CoV-2 Variant of Concern B.1.1.7
- Overview of ACE-2 Receptor, Its Structure and Polymorphism and its Susceptibility to SARS-Cov-2, Influences of COVID-19 on Multi-Organs Cardiovascular Comorbidities, and COVID-19 Disease Outcome
- SARS-CoV-2 Mutations, Origin of Variants and Prediction of Mutations to Control Severe Diseases in Humans
- Covid-19 (SARS-CoV-2) VS Sars-CoV; Summary of all things that healthcare providers should know |Biomedgrid